The erythropoietin-derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post-status epilepticus model

Epilepsia

Volumn 52, Issue 12, 2011, Pages 2333-2343

  Seeger, Natalie ^a   Zellinger, Christina ^a   Rode, Ariane ^a   Roloff, Frank ^b   Bicker, Gerd ^b   Russmann, Vera ^a   Fischborn, Sarah ^a   Wendt, Hannes ^a   Potschka, Heidrun ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Cognition; Erythropoietin; Neurogenesis; Peptide mimetic; pHBSP; Status epilepticus

Indexed keywords

BROXURIDINE; HBSP PEPTIDE; PEPTIDOMIMETIC AGENT; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; EPILEPTIC STATE; FEMALE; HIPPOCAMPUS; MAZE TEST; MICROGLIA; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

ADAPTATION, PHYSIOLOGICAL; ANALYSIS OF VARIANCE; ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ERYTHROPOIETIN; EXPLORATORY BEHAVIOR; FEMALE; HUMANS; MAZE LEARNING; MICROGLIA; NEUROGENESIS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; SERINE ENDOPEPTIDASES; STATUS EPILEPTICUS;

EID: 82955247663     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03302.x     Document Type: Article

References (53)

1. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P,. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952: 128-134. (Pubitemid 35279495)
2. Boissel JP, Lee WR, Presnell SR, Cohen FE, Bunn HF,. (1993) Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. J Biol Chem 268: 15983-15993. (Pubitemid 23222105)
3. Brandt C, Glien M, Potschka H, Volk H, Loscher W,. (2003a) Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res 55: 83-103. (Pubitemid 37011375)
4. Brandt C, Potschka H, Loscher W, Ebert U,. (2003b) N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118: 727-740. (Pubitemid 36506960)
5. Brandt C, Gastens AM, Sun M, Hausknecht M, Loscher W,. (2006) Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51: 789-804. (Pubitemid 44286933)
6. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A,. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 101: 14907-14912. (Pubitemid 39410773)
7. Brines M, Patel NS, Villa P, Brines C, Mennini T, De Paola M, Erbayraktar Z, Erbayraktar S, Sepodes B, Thiemermann C, Ghezzi P, Yamin M, Hand CC, Xie QW, Coleman T, Cerami A,. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 105: 10925-10930.
8. Cheetham JC, Smith DM, Aoki KH, Stevenson JL, Hoeffel TJ, Syed RS, Egrie J, Harvey TS,. (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol 5: 861-866. (Pubitemid 28467406)
9. Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT,. (2007) Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282: 25875-25883. (Pubitemid 47372832)
10. Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK, Lim JS, Park HK, Kim M, Lee SK, Roh JK,. (2008) Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 49: 1723-1732.
11. Crawley JN,. (1981) Neuropharmalogic specifity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 5: 695-699. (Pubitemid 12195249)
12. Del Rio JA, Soriano E,. (1989) Immunocytochemical detection of 5′-bromdesoxyuridine in corporation in the central nervous system of the mouse. Brain Res Dev Brain Res 492: 311-317. (Pubitemid 19250383)
13. D'Hooge R, De Deyn PP,. (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36: 60-90. (Pubitemid 32763130)
14. Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, Siren AL, Paulus W, Nave KA, Gold R, Bartels C,. (2007a) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130: 2577-2588. (Pubitemid 47511714)
15. Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, Heinz G, Erdag S, Jahn H, Degner D, Ritzen M, Mohr A, Wagner M, Schneider U, Bohn M, Huber M, Czernik A, Pollmacher T, Maier W, Siren AL, Klosterkotter J, Falkai P, Ruther E, Aldenhoff JB, Krampe H,. (2007b) Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12: 206-220. (Pubitemid 46160985)
16. Elliott S, Lorenzini T, Chang D, Barzilay J, Delorme E,. (1997) Mapping of the active site of recombinant human erythropoietin. Blood 89: 493-502. (Pubitemid 27051684)
17. Esneault E, Pacary E, Eddi D, Freret T, Tixier E, Toutain J, Touzani O, Schumann-Bard P, Petit E, Roussel S, Bernaudin M,. (2008) Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 28: 1552-1563.
18. File SE,. (1993) The interplay of learning and anxiety in the elevated-plus-maze. Behav Brain Res 58: 199-202.
19. Fujikawa DG, Shinmei SS, Cai B,. (2000) Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 41 (Suppl. 6): S9-S13.
20. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, Ferriero DM,. (2007) Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29: 321-330. (Pubitemid 47343686)
21. Goodman T, Trouche S, Massou I, Verret L, Zerwas M, Roullet P, Rampon C,. (2010) Young hippocampal neurons are critical for recent and remote spatial memory in adult mice. Neuroscience 171: 769-778.
22. Kobilo T, Yuan C, van Praag H,. (2011) Endurance factors improve hippocampal neurogenesis and spatial memory in mice. Learn Mem 18: 103-107.
23. Koneski JA, Casella EB,. (2010) Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment. Arq Neuropsiquiatr 68: 107-114.
24. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M,. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242. (Pubitemid 38886736)
25. Loscher W, Brandt C,. (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62: 668-700.
26. Lu D, Mahmood A, Qu C, Goussev A, Schallert T, Chopp M,. (2005) Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22: 1011-1017. (Pubitemid 41362067)
27. Miskowiak K, O'Sullivan U, Harmer CJ,. (2007) Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action. Biol Psychiatry 62: 1244-1250. (Pubitemid 350060886)
28. Miskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ,. (2008a) Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res 184: 313-321. (Pubitemid 350275880)
29. Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ,. (2008b) Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology 33: 611-618.
30. Molina-Holgado F, Doherty P, Williams G,. (2008) Tandem repeat peptide strategy for the design of neurotrophic factor mimetics. CNS Neurol Disord Drug Targets 7: 110-119. (Pubitemid 351516221)
31. Morris R,. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60. (Pubitemid 14088970)
32. Nadam J, Navarro F, Sanchez P, Moulin C, Georges B, Laglaine A, Pequignot JM, Morales A, Ryvlin P, Bezin L,. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 25: 412-426. (Pubitemid 46138046)
33. Nissenson AR,. (1989) Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 9: 25-31. (Pubitemid 19159980)
34. Packard DS Jr, Menzies RA, Skalko RG,. (1973) Incorporation of thymidine and its analogue, bromodeoxyuridine, into embryos and maternal tissues of the mouse. Differentiation 6: 397-404.
35. Pankratova S, Kiryushko D, Sonn K, Soroka V, Kohler LB, Rathje M, Gu B, Gotfryd K, Clausen O, Zharkovsky A, Bock E, Berezin V,. (2010) Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain 133: 2281-2294.
36. Parent JM, Murphy GG,. (2008) Mechanisms and functional significance of aberrant seizure-induced hippocampal neurogenesis. Epilepsia 49 (Suppl. 5): 19-25. (Pubitemid 351782997)
37. Pekcec A, Muhlenhoff M, Gerardy-Schahn R, Potschka H,. (2007) Impact of the PSA-NCAM system on pathophysiology in a chronic rodent model of temporal lobe epilepsy. Neurobiol Dis 27: 54-66. (Pubitemid 46921474)
38. Pekcec A, Fuest C, Muhlenhoff M, Gerardy-Schahn R, Potschka H,. (2008) Targeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development. J Neurochem 105: 389-400. (Pubitemid 351490022)
39. Pitkanen A, Lukasiuk K,. (2009) Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14 (Suppl. 1): 16-25.
40. Prut L, Belzung C,. (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33. (Pubitemid 36205070)
41. Rabie T, Marti HH,. (2008) Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 23: 263-274.
42. Racine RJ,. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.
43. Ransome MI, Turnley AM,. (2007) Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis. J Neurochem 102: 1953-1965. (Pubitemid 47329277)
44. Scharfman HE, McCloskey DP,. (2009) Postnatal neurogenesis as a therapeutic target in temporal lobe epilepsy. Epilepsy Res 85: 150-161.
45. Shapiro LA, Ribak CE, Jessberger S,. (2008) Structural changes for adult-born dentate granule cells after status epilepticus. Epilepsia 49 (Suppl. 5): 13-18. (Pubitemid 351782996)
46. Shingo T, Sorokan ST, Shimazaki T, Weiss S,. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21: 9733-9743. (Pubitemid 34184059)
47. Skaper SD,. (2008) The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 7: 46-62. (Pubitemid 351516216)
48. Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael ST,. (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26: 1269-1274. (Pubitemid 43237059)
49. Unkrüer B, Pekcec A, Fuest C, Wehmeyer A, Balda MS, Horn A, Baumgärtner W, Potschka H,. (2009) Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans. BMC Neurosci 10: 28.
50. Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P,. (2010) Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther 128: 445-459.
51. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M,. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35: 1732-1737. (Pubitemid 38823656)
52. Wen D, Boissel JP, Showers M, Ruch BC, Bunn HF,. (1994) Erythropoietin structure-function relationships. Identification of functionally important domains. J Biol Chem 269: 22839-22846.
53. Wolcott DL, Marsh JT, La Rue A, Carr C, Nissenson AR,. (1989) Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14: 478-485. (Pubitemid 20057895)